TY  - JOUR
AU  - Quintanal Villalonga, Álvaro
AU  - Ojeda Márquez, Laura
AU  - López-Ríos Moreno, Fernando
AU  - Paz-Ares Rodríguez, Luis Gonzaga
PY  - 2020
DO  - 10.1016/J.EBIOM.2020.102683
SN  - 32114392
SN  - 2352-3964
UR  - https://hdl.handle.net/20.500.14352/118240
T2  - EBioMedicine
AB  - BackgroundFibroblast growth factor receptor (FGFR)1 and FGFR4 have been associated with tumorigenesis in a variety of tumour types. As a therapeutic approach, their inhibition has been attempted in different types of malignancies, including lung...
LA  - eng
PB  - Elsevier
KW  - FGFR inhibitors
KW  - FGFR1
KW  - FGFR4
KW  - N-cadherin
KW  - Predictive biomarker
TI  - FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy
TY  - journal article
VL  - 53
ER  -